MEA

We provide laboratory service of high-end drug screening for cardiac properties.
We offer multi-parametric assays analyzing a wide range of functional properties (comprising the excitation-contraction coupling machinery) in human embryonic stem cells-derived cardiomyocytes, and cultured neonatal rat and mouse ventricular myocytes.

Activity:

- Contract Research

Product / Technology type(s) covered:

- Technology

Therapeutic targets:

- Cardiovascular

Markets Covered

a. HeadQuarter: Israel

b. Continent(s) active: North America , Europe , Australia/New-Zealand

c. Countries active: USA, UK, France etc.

Corporate data:

Number of Employees: 5

Turnover:

Amount:	Year:	Currency:
0	2002	US Dollar

Year founded: 2004